日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer.

确定 TNIK-CDK9 轴作为铂耐药卵巢癌的靶向治疗策略

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-24-0785
Puleo Noah, Ram Harini, Dziubinski Michele L, Carvette Dylan, Teitel Jessica, Sekhar Sreeja C, Bedi Karan, Robida Aaron, Nakashima Michael M, Farsinejad Sadaf, Iwanicki Marcin, Senkowski Wojciech, Ray Arpita, Bollerman Thomas J, Dunbar James, Richardson Peter, Taddei Andrea, Hudson Chantelle, DiFeo Analisa
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate

Brn-3a转录因子在体外和体内均能阻断p53介导的促凋亡靶基因Noxa和Bax的激活，从而决定细胞命运。

期刊:Journal of Biological Chemistry
影响因子:3.9
doi:10.1074/jbc.A116.408679
Hudson, Chantelle D; Morris, Peter J; Latchman, David S; Budhram-Mahadeo, Vishwanie S
细胞生物学
凋亡
表观遗传
发表日期：2016
文献求助 收藏

Two Types of Novel Allosteric Modulators Activate β(2)-AR Signaling, a G Protein-coupled Receptor Involved in Airway Smooth Muscle Relaxation and Asthma♦: Development and Characterization of Pepducins as G(s)-biased Allosteric Agonists

两种新型变构调节剂激活β(2)-肾上腺素能受体信号通路，该受体是一种参与气道平滑肌舒张和哮喘的G蛋白偶联受体♦：肽类药物作为G(s)偏向性变构激动剂的开发和表征

期刊:Journal of Biological Chemistry
影响因子:3.9
doi:10.1074/jbc.A115.690198
Cobb, Melanie M; Austin, Daniel C; Sack, Jon T; Trimmer, James S; Hudson, Chantelle D; Morris, Peter J; Latchman, David S; Budhram-Mahadeo, Vishwanie S
信号转导
哮喘
免疫/内分泌
发表日期：2014
文献求助 收藏